D-serine Monotherapy for Schizophrenia

NCT00816894 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: D-serine
DRUG: Olanzapine

Sponsor

Herzog Hospital

Collaborators

[object Object]